In this review, we describe how clinical investigators addressed some of the challenges in prostate cancer chemotherapy trials 20 years ago, and we indicate what has evolved in the field since that time. We consider the impact that prostate-specific antigen measurement had in this setting, evolving clinical paradigms, multidisciplinary programs, and the current armamentarium of cancer treatment, including targeted molecular therapy, for patients with hormone-refractory disease.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
prostate cancer
8
role cytotoxic
4
cytotoxic chemotherapy
4
chemotherapy prostate
4
cancer critical
4
critical reevaluation
4
reevaluation years
4
years review
4
review describe
4
describe clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!